Wegovy for weight loss: Can you overcome the weight loss plateau?
Semaglutide drugs, used to treat type 2 diabetes, also help with weight management. One such drug, sold under the brand name Wegovy, is approved as a treatment for overweight and obesity. But why do some people hit a weight loss plateau on Wegovy? We explore this topic with our expert guest In Conversation.
Semaglutide, or GLP-1 receptor agonist drugs, are typically prescribed to people with type 2 diabetes to help them with blood sugar management by prompting their bodies
These drugs can also help with weight loss by suppressing a person’s appetite. At the moment, however, only one semaglutide drug is approved as a weight management aid in people with overweight and obesity in the
Still, a significant number of people who use semaglutide report hitting a weight loss plateau that they find difficult to overcome.
How does semaglutide help with weight management, why do some people on Wegovy hit a weight loss plateau, and what are some issues to keep in mind when it comes to using semaglutide for weight loss?
In this instalment of our In Conversation podcast, Dr. Simon Cork, senior lecturer in the Faculty of Health, Medicine and Social Care at Anglia Ruskin University in the United Kingdom helps us answer these and more questions.
Listen to our podcast episode in full below or on your preferred streaming platform.
 |  |  |
For more information on the weight loss plateau on semaglutide, you can read our article, “Why weight loss drugs stop working and how to break past the Ozempic plateau.”
Recommended Reading
What is the Atlantic Diet? Experts Explain Benefits
What is the Atlantic Diet? Experts Explain Benefits What is the Atlantic Diet? Experts Explain Benefits
Analysis-Chinese developers resume UK commercial property retreat
Analysis-Chinese developers resume UK commercial property retreat Analysis-Chinese developers resume UK commercial property retreat
Analysis-Boeing's Spirit Aero bid could help supply chain but is no cure-all
Analysis-Boeing's Spirit Aero bid could help supply chain but is no cure-all Analysis-Boeing's Spirit Aero bid could help supply chain but is no cure-all
Analysis-Strong U.S. economy sends dollar bears into hibernation
Analysis-Strong U.S. economy sends dollar bears into hibernation Analysis-Strong U.S. economy sends dollar bears into hibernation
Brain fog in long COVID: Vascular leaks around brain may be at fault
Brain fog in long COVID: Vascular leaks around brain may be at fault Brain fog in long COVID: Vascular leaks around brain may be at fault
China's BYD prices new version of best-selling EV lower than predecessor
China's BYD prices new version of best-selling EV lower than predecessor China's BYD prices new version of best-selling EV lower than predecessor
Asian stocks dip ahead of more China cues; Nikkei coasts past 40,000
Asian stocks dip ahead of more China cues; Nikkei coasts past 40,000 Asian stocks dip ahead of more China cues; Nikkei coasts past 40,000
Stellantis "recall" tiga mobil di AS, termasuk Jeep
Stellantis "recall" tiga mobil di AS, termasuk Jeep Stellantis "recall" tiga mobil di AS, termasuk Jeep
:max_bytes(150000):strip_icc()/omar-carter-202205-1653123721-rt-3f9efc953ccd467399338e50cd5bad8d.jpg?id=1)
Omar Carter's Story: Young, Black Athlete Suffers Cardiac Arrest on Court
Omar Carter's Story: Young, Black Athlete Suffers Cardiac Arrest on Court Omar Carter's Story: Young, Black Athlete Suffers Cardiac Arrest on Court
Vista Outdoor gets $2.9 billion takeover offer, WSJ reports
Vista Outdoor gets $2.9 billion takeover offer, WSJ reports Vista Outdoor gets $2.9 billion takeover offer, WSJ reports
Oil prices set for weekly gains on US rate hopes, OPEC supply signals
Oil prices set for weekly gains on US rate hopes, OPEC supply signals Oil prices set for weekly gains on US rate hopes, OPEC supply signals
Could sun exposure have a positive effect on female fertility?
Could sun exposure have a positive effect on female fertility? Could sun exposure have a positive effect on female fertility?